Form 8-K - Current report:
SEC Accession No. 0001213900-20-045508
Filing Date
2020-12-31
Accepted
2020-12-30 17:47:08
Documents
4
Period of Report
2020-12-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea132464-8k_wizephar.htm 8-K 17623
2 PRESS RELEASE, DATED DECEMBER 30, 2020: WIZE PHARMA AND COSMOS CAPITAL ENTER INT ea132464ex99-1_wizephar.htm EX-99.1 25970
3 GRAPHIC image_001.jpg GRAPHIC 7788
4 GRAPHIC image_002.jpg GRAPHIC 14504
  Complete submission text file 0001213900-20-045508.txt   75839
Mailing Address 24 HANAGAR ST HOD HASHARON L3 4527713
Business Address 24 HANAGAR ST HOD HASHARON L3 4527713 972 472 260 0536
Wize Pharma, Inc. (Filer) CIK: 0001218683 (see all company filings)

EIN.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52545 | Film No.: 201426907
SIC: 2834 Pharmaceutical Preparations